Drug Profile
Metiapril
Alternative Names: MethioprilLatest Information Update: 09 Dec 1998
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Antihypertensives; Heart failure therapies; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Heart failure; Hypertension
Most Recent Events
- 09 Dec 1998 No-Development-Reported for Heart failure in Russia (Unknown route)
- 09 Dec 1998 No-Development-Reported for Hypertension in Russia (Unknown route)
- 14 Oct 1998 Profile reviewed